Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-25 @ 5:01 PM
NCT ID:
NCT00005803
Group ID:
EG000
Title:
Treatment (Tandem Transplantation)
Description:
See Detailed Description
Autologous Hematopoietic Stem Cell Transplantation: Undergo autologous transplantation
Autologous-Allogeneic Tandem Hematopoietic Stem Cell Transplantation: Undergo autologous-allogeneic tandem hematopoietic stem cell transplantation
Carmustine: Given IV
Cyclophosphamide: Given IV
Cyclosporine: Given PO
Cytarabine: Given IV
Etoposide: Given IV
Fludarabine Phosphate: Given IV
Laboratory Biomarker Analysis: Correlative studies
Melphalan: Given IV
Mycophenolate Mofetil: Given PO
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Undergo allogeneic transplantation
Peripheral Blood Stem Cell Transplantation: Undergo allogeneic transplantation
Therapeutic Autologous Lymphocytes: IV donor lymphocyte infusion
Total-Body Irradiation: Undergo radiotherapy
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
10
Serious Number At Risk:
76
Other Number Affected:
24
Other Number At Risk:
76
Study:
NCT00005803
Results Section:
NCT00005803
Adverse Events Module:
NCT00005803